Huiying Rao

3.1k total citations
126 papers, 1.7k citations indexed

About

Huiying Rao is a scholar working on Hepatology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Huiying Rao has authored 126 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Hepatology, 85 papers in Epidemiology and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Huiying Rao's work include Liver Disease Diagnosis and Treatment (70 papers), Hepatitis C virus research (63 papers) and Hepatitis B Virus Studies (44 papers). Huiying Rao is often cited by papers focused on Liver Disease Diagnosis and Treatment (70 papers), Hepatitis C virus research (63 papers) and Hepatitis B Virus Studies (44 papers). Huiying Rao collaborates with scholars based in China, United States and Singapore. Huiying Rao's co-authors include Lai Wei, Terry L. Amburgey, Lai Wei, Feng Liu, Bo Feng, Ran Fei, Anna S. Lok, Jingmin Zhao, Rui Huang and Ruifeng Yang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Academy of Management Journal and PLoS ONE.

In The Last Decade

Huiying Rao

117 papers receiving 1.6k citations

Peers

Huiying Rao
Marc Bilodeau Canada
Zhengwen Liu China
Bettina Borisch Switzerland
Sun Lee United States
Pabak Mukhopadhyay United States
Li-Yu Chen China
Chi-Chung Cheng China
Jiangxia Liu China
Ian W. Gibson Canada
Kristien M.A.J. Tytgat Netherlands
Marc Bilodeau Canada
Huiying Rao
Citations per year, relative to Huiying Rao Huiying Rao (= 1×) peers Marc Bilodeau

Countries citing papers authored by Huiying Rao

Since Specialization
Citations

This map shows the geographic impact of Huiying Rao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiying Rao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiying Rao more than expected).

Fields of papers citing papers by Huiying Rao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huiying Rao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiying Rao. The network helps show where Huiying Rao may publish in the future.

Co-authorship network of co-authors of Huiying Rao

This figure shows the co-authorship network connecting the top 25 collaborators of Huiying Rao. A scholar is included among the top collaborators of Huiying Rao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huiying Rao. Huiying Rao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Runling, Haiying Zhang, Zhang Li, et al.. (2025). Clinical indications and Z-score-assisted NIPT testing: a new perspective in prenatal screening. SHILAP Revista de lepidopterología. 5(1). e000187–e000187.
2.
3.
Liu, Feng, Yameng Sun, Dean Tai, et al.. (2024). AI Digital Pathology Using qFibrosis Shows Heterogeneity of Fibrosis Regression in Patients with Chronic Hepatitis B and C with Viral Response. Diagnostics. 14(16). 1837–1837. 2 indexed citations
4.
Liu, Huixin, Xiaoxiao Wang, Lijun Wang, et al.. (2024). Mortality Burden of Liver Cancer in China: An Observational Study From 2008 to 2020. Journal of Clinical and Translational Hepatology. 12(4). 371–380. 6 indexed citations
5.
Wang, Xiaoxiao, et al.. (2024). Hub Genes Involved in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma. Current Medicinal Chemistry. 32(23). 4786–4804. 1 indexed citations
6.
Golé, Laurent, Feng Liu, Kok Haur Ong, et al.. (2023). Quantitative image-based collagen structural features predict the reversibility of hepatitis C virus-induced liver fibrosis post antiviral therapies. Scientific Reports. 13(1). 6384–6384. 4 indexed citations
7.
Yang, Jia, Jinlei Qi, Xiaohe Li, et al.. (2023). The burden of hepatitis C virus in the world, China, India, and the United States from 1990 to 2019. Frontiers in Public Health. 11. 1041201–1041201. 27 indexed citations
8.
Wang, Xiaoxiao, Zilong Wang, Ran Fei, et al.. (2023). Characteristic gene expression in the liver monocyte-macrophage-DC system is associated with the progression of fibrosis in NASH. Frontiers in Immunology. 14. 7 indexed citations
9.
Zhang, Wei, Grace L. Su, Rui Huang, et al.. (2022). Metabolic abnormalities, liver and body fat in American versus Chinese patients with non‐alcoholic fatty liver disease. JGH Open. 6(8). 519–530. 2 indexed citations
10.
Zhang, Haiying, Ying Ji, Cong Xu, et al.. (2022). Inactivated Vaccines Against SARS-CoV-2: Neutralizing Antibody Titers in Vaccine Recipients. Frontiers in Microbiology. 13. 816778–816778. 15 indexed citations
11.
Dong, Wen‐Liang, Xia Lin, Jiaxue Wang, et al.. (2021). Pharmacokinetic bioequivalence, safety, and immunogenicity of GB222, a bevacizumab biosimilar candidate, and bevacizumab in Chinese healthy males: a randomized clinical trial. Expert Opinion on Biological Therapy. 22(2). 253–262. 1 indexed citations
12.
Chen, Xiaomei, et al.. (2021). Nomogram Prediction Model for Diabetic Retinopathy Development in Type 2 Diabetes Mellitus Patients: A Retrospective Cohort Study. Journal of Diabetes Research. 2021. 1–8. 15 indexed citations
13.
Jin, Rui, Lihua Wang, Hui Ma, et al.. (2020). Correlation between anti-mitochondrial antibodies and clinical serological and cirrhotic markers of primary biliary cholangitis. Zhonghua xiaohua zazhi. 40(1). 16–22.
14.
Li, Mingjie, Jian Dong, Huiying Rao, et al.. (2020). A synonymous mutation in exon 39 of FBN1 causes exon skipping leading to Marfan syndrome. Genomics. 112(6). 3856–3861. 6 indexed citations
15.
Liu, Feng, George Boon‐Bee Goh, Dina Tiniakos, et al.. (2019). qFIBS: An Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis. Hepatology. 71(6). 1953–1966. 82 indexed citations
16.
17.
Rao, Huiying, Lai Wei, Hong Li, et al.. (2015). Prevalence of abnormal glycometabolism in treatment‐naive patients with hepatitis C virus infection in a C hinese H an population. Journal of Gastroenterology and Hepatology. 30(6). 1049–1056. 5 indexed citations
18.
Shang, Jia, Xiaoyuan Xu, Xinyue Chen, et al.. (2015). Efficacy and related factors of pegylated interferon α-2a plus ribavirin therapy for chronic hepatitis C in non-responders. 8(3). 232–237. 1 indexed citations
19.
Rao, Huiying & Lai Wei. (2011). [Introduction and comments on EASL clinical practice guidelines: management of hepatitis C virus infection].. PubMed. 19(5). 391–4. 118 indexed citations
20.
Rao, Huiying, et al.. (2011). 1339 IL28B GENETIC VARIANTS AND GENDER ARE ASSOCIATED WITH SPONTANEOUS CLEARANCE OF HEPATITIS C VIRUS INFECTION. Journal of Hepatology. 54. S529–S529. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marc Bilodeau Breakdown of academic impact, for papers by Zhengwen Liu Breakdown of academic impact, for papers by Bettina Borisch Breakdown of academic impact, for papers by Sun Lee Breakdown of academic impact, for papers by Pabak Mukhopadhyay Breakdown of academic impact, for papers by Li-Yu Chen Breakdown of academic impact, for papers by Chi-Chung Cheng Breakdown of academic impact, for papers by Jiangxia Liu Breakdown of academic impact, for papers by Ian W. Gibson Breakdown of academic impact, for papers by Kristien M.A.J. Tytgat
Rankless by CCL
2026